Skip to main content
Clinical Trials/NCT07184203
NCT07184203RecruitingNot Applicable

Comparative Clinicomycologic and Dermoscopic Study Between Daily and Pulse Therapy of Oral Itraconazole in Tinea Capitis in Children

Alexandria University1 site in 1 country120 target enrollmentStarted: March 9, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
120
Locations
1
Primary Endpoint
improvement of tinea capitis

Study Overview

Brief Summary

A study to compare the efficacy of daily therapy versus pulse therapy of oral itraconazole in the treatment of tinea capitis in children based on clinical, mycological and dermoscopic evaluation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
5 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Tinea capitis patients with ages ranging from 5 to 18 year

Exclusion Criteria

  • Patients with contraindications to itraconazole
  • Patients with associated scalp disease.
  • Patients weighing less than 20 Kg.

Arms & Interventions

Group A will receive itraconazole continuous daily regimen

Active Comparator

Intervention: Itraconazole (ITZ) (Drug)

Group B will receive itraconazole pulse regimen

Active Comparator

Intervention: Itraconazole (ITZ) (Drug)

Outcomes

Primary Outcomes

improvement of tinea capitis

Time Frame: 3 months

cure of tinea capitis

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Marina Aioub

general practitioner

Alexandria University

Study Sites (1)

Loading locations...

Similar Trials

Comparison Between Continuous and Pulse... | Clinical Trial